Light Mode
$79.16 ↑ +0.60 (+0.76%) Trading Up from the previous close of $78.56
+19.24 (+32.43%) / 6M
Momentum, market sentiment, and recent alerts
DXCM reads neutral: price sits above one of the two key moving averages, the 12-month move is +13.5%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.